Latest Research in Monoclonal and Polyclonal Antibodies Research
31 research papers · 2026 median publication year
Top Research Topics in Monoclonal and Polyclonal Antibodies Research
- Acute Myeloid Leukemia Research — 4 papers
- Monoclonal and Polyclonal Antibodies Research — 2 papers
- MicroRNA in disease regulation — 2 papers
- Advanced Breast Cancer Therapies — 2 papers
- Cancer Immunotherapy and Biomarkers — 2 papers
- CAR-T cell therapy research — 2 papers
- Immune Cell Function and Interaction — 2 papers
- Cancer-related gene regulation — 2 papers
- Radiopharmaceutical Chemistry and Applications — 1 papers
- Acute Lymphoblastic Leukemia research — 1 papers
Highest-Cited Papers
- Albumin uptake through FcRn promotes tumor-associated macrophage maturation and albumin-bound immunotherapy response
- Candidate Regulatory Relationship and Expression Correlation Between miR-33a-5p and ANK3 in Chronic Myeloid Leukemia
- The sensitivity of acute myeloid leukemia to CDK8/19 inhibitors is determined by their metabolic profile
- Functional exhaustion of human follicular cytotoxic T cells is associated with CEACAM1 expression and dysregulation of the SHP1–LCK–ZAP70 signaling axis
- An active TCA cycle state defines a high-risk acute lymphoblastic leukemia subtype
- Tumor microenvironment-activatable virus-mimetic reactors reprogram cell fate-defining repressive epigenetic machineries to augment radio-immunotherapy
- Decondensing cancer immunotherapy
- In vivo genome-wide CRISPR screens identify FOXR1 as a suppressor of CD8 + T cell antitumor immunity
- The Expression of Notch1 and Notch2 is Up-Regulated on Natural Killer Cells by the Interaction Between NKp46 and Syndecan-1 in a Mouse Breast Cancer Model
- Spatiotemporal CD8 + T‐Cell Dynamics: Clonal Replacement and Expansion as Determinants of Sustainable Antitumor Response
- The Immune Rheostat: A Shared Regulatory Axis Linking Cancer Immune Evasion and Autoimmune Activation
- PRMT7 restricts CD8+ T cells expansion via the NF-ΚB pathway
- Engineering microRNAs as multimodal cancer therapeutics
- Restoration of tumor vascular integrity by P188 improves chemotherapy and immunotherapy efficacy in triple negative breast cancer
- Exploiting Bridged Conformations for Precise Molecular Recognition in the Design of KRAS-Selective, Orally Available Macrocyclic Peptides
- Therapy induced senescence promotes immunogenicity in acute myeloid Leukemia through reduced EZH2 activity
- Intratumoral injection of EpCAM BITE, IL-12, and GM-CSF mRNA-LNPs blocks the growth of local treated and distant untreated tumors
- Research advances on CD47 in digestive system cancers: from molecular mechanisms to clinical translation
- Therapy-persistent leukemia is selectively vulnerable to SLC23A1 restoration via targeting KHSRP
- AML1-ETO hijacks a distal enhancer of NAT10 to reprogram glutathione metabolism and sustain leukemia stem cell stemness